...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: Resverlogix Announces Commencement of Patient Enrollment and Dosing in a Phase 2b Trial for a Promising Canadian-Developed COVID-19 Treatment

"I doubt Eversana can announce anything until this news release was first made public.  But I assume they will be a fast follower now."

I suspect that Eversana will make "Apabetalone/COVID-19" public once they know that it works and not before. They will only back up a successful study.

 

Just saying ... Koo

Share
New Message
Please login to post a reply